Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Targeted Next-generation Sequencing on Hospitalized Patients With Community-acquired Pneumonia and Initial Treatment Failure

NCT07472114 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT07472114
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07472114 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Targeted Next-generation Sequencing on Hospitalized Patients With Community-acquired Pneumonia and Initial Treatment Failure
Lead sponsor
Capital Medical University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
April 10, 2026
Completion date
February 28, 2028
Enrollment
524 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

community acquired pneumonia (cap)